BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $652,002 | -17.0% | 17,276 | +0.2% | 0.29% | -15.4% |
| Q2 2023 | $785,279 | +1.4% | 17,236 | -9.7% | 0.34% | +5.3% |
| Q1 2023 | $774,459 | -25.3% | 19,094 | -6.1% | 0.32% | -24.3% |
| Q4 2022 | $1,036,177 | -5.3% | 20,329 | 0.0% | 0.42% | -16.2% |
| Q3 2022 | $1,094,000 | -16.2% | 20,329 | 0.0% | 0.51% | -11.5% |
| Q2 2022 | $1,305,000 | -17.2% | 20,329 | 0.0% | 0.57% | -9.9% |
| Q1 2022 | $1,576,000 | -9.7% | 20,329 | 0.0% | 0.64% | -7.4% |
| Q4 2021 | $1,745,000 | +6.7% | 20,329 | 0.0% | 0.69% | +2.7% |
| Q3 2021 | $1,635,000 | -0.1% | 20,329 | 0.0% | 0.67% | +0.9% |
| Q2 2021 | $1,636,000 | -5.6% | 20,329 | -1.1% | 0.66% | -12.4% |
| Q1 2021 | $1,733,000 | +5.1% | 20,554 | 0.0% | 0.76% | -7.5% |
| Q4 2020 | $1,649,000 | -1.2% | 20,554 | -1.0% | 0.82% | -7.8% |
| Q3 2020 | $1,669,000 | -6.6% | 20,754 | 0.0% | 0.89% | -11.3% |
| Q2 2020 | $1,786,000 | -1.7% | 20,754 | -7.2% | 1.00% | -19.2% |
| Q1 2020 | $1,816,000 | -10.4% | 22,374 | -7.7% | 1.24% | +11.4% |
| Q4 2019 | $2,026,000 | -3.5% | 24,234 | +0.9% | 1.11% | -13.3% |
| Q3 2019 | $2,100,000 | -1.2% | 24,019 | -7.5% | 1.28% | +0.8% |
| Q2 2019 | $2,126,000 | -23.5% | 25,966 | -24.1% | 1.27% | -24.3% |
| Q1 2019 | $2,780,000 | +5.2% | 34,201 | -14.9% | 1.68% | -8.6% |
| Q4 2018 | $2,643,000 | -14.6% | 40,166 | 0.0% | 1.84% | -3.3% |
| Q3 2018 | $3,096,000 | +4.0% | 40,166 | -0.4% | 1.90% | -4.5% |
| Q2 2018 | $2,978,000 | +3.9% | 40,341 | -8.5% | 1.99% | +1.0% |
| Q1 2018 | $2,866,000 | -7.7% | 44,076 | -8.3% | 1.97% | -3.8% |
| Q4 2017 | $3,105,000 | -3.4% | 48,046 | -6.2% | 2.05% | -8.1% |
| Q3 2017 | $3,213,000 | +1.3% | 51,211 | -2.2% | 2.23% | -4.4% |
| Q2 2017 | $3,171,000 | +3.1% | 52,381 | -11.7% | 2.34% | +3.0% |
| Q1 2017 | $3,075,000 | +12.8% | 59,297 | -3.5% | 2.27% | +15.2% |
| Q4 2016 | $2,725,000 | -7.3% | 61,457 | -0.5% | 1.97% | -9.7% |
| Q3 2016 | $2,941,000 | +6.1% | 61,789 | +0.8% | 2.18% | +5.8% |
| Q2 2016 | $2,771,000 | +19.9% | 61,291 | +9.0% | 2.06% | +18.9% |
| Q1 2016 | $2,311,000 | +7.8% | 56,256 | +0.1% | 1.74% | +2.4% |
| Q4 2015 | $2,144,000 | +12.4% | 56,201 | -3.3% | 1.70% | +9.4% |
| Q3 2015 | $1,908,000 | -49.5% | 58,101 | +7.6% | 1.55% | -45.5% |
| Q2 2015 | $3,775,000 | +2.3% | 53,986 | +0.2% | 2.84% | +0.5% |
| Q1 2015 | $3,691,000 | -5.0% | 53,886 | +1.7% | 2.83% | +0.8% |
| Q4 2014 | $3,884,000 | +14.0% | 52,996 | +11.6% | 2.81% | +6.3% |
| Q3 2014 | $3,407,000 | -0.7% | 47,471 | +0.0% | 2.64% | +0.3% |
| Q2 2014 | $3,430,000 | +0.8% | 47,451 | +2.6% | 2.63% | -4.7% |
| Q1 2014 | $3,402,000 | +5.8% | 46,239 | 0.0% | 2.76% | +5.0% |
| Q4 2013 | $3,215,000 | +7.3% | 46,239 | +1.4% | 2.63% | -1.8% |
| Q3 2013 | $2,996,000 | -4.9% | 45,617 | +0.3% | 2.68% | -8.0% |
| Q2 2013 | $3,149,000 | – | 45,472 | – | 2.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |